ZORDOBA Trademark

Trademark Overview


On Thursday, January 28, 2021, a trademark application was filed for ZORDOBA with the United States Patent and Trademark Office. The USPTO has given the ZORDOBA trademark a serial number of 90492029. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 30, 2024. This trademark is owned by Novartis AG. The ZORDOBA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
zordoba

General Information


Serial Number90492029
Word MarkZORDOBA
Filing DateThursday, January 28, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 29, 2021

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Translation of Words in MarkThe wording "ZORDOBA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4002
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4002
CH

Trademark Events


Event DateEvent Description
Monday, February 1, 2021NEW APPLICATION ENTERED
Wednesday, June 9, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 27, 2021ASSIGNED TO EXAMINER
Thursday, May 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 29, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 22, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 29, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 24, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 22, 2022SOU EXTENSION 1 FILED
Tuesday, February 22, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 21, 2023SOU EXTENSION 3 GRANTED
Thursday, February 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 24, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, August 24, 2022SOU EXTENSION 2 FILED
Wednesday, August 24, 2022SOU EXTENSION 2 GRANTED
Friday, August 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 21, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 21, 2023SOU EXTENSION 3 FILED
Thursday, February 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 20, 2024SOU EXTENSION 5 GRANTED
Tuesday, February 20, 2024SOU EXTENSION 5 FILED
Monday, September 30, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 30, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, February 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 5, 2023SOU EXTENSION 4 FILED
Saturday, August 5, 2023SOU EXTENSION 4 GRANTED
Tuesday, August 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 20, 2024SOU TEAS EXTENSION RECEIVED